ALYSSA VAN METER: Open Payments
NPI 1073085593 · LELAND, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 21 payments from 7 companies in 2025. Trend: 2023 $533 · 2024 $471 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $180 |
| Novo Nordisk Inc | 6 | $115 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Organon LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| PFIZER INC. | 1 | $14 |
Products named: QULIPTA, VRAYLAR, Ozempic, Wegovy, NEXPLANON, REXULTI, ROTATEQ, SHINGRIX.
Industry payments across NC — which companies pay providers there.
